JAIDS supplement: Post-program learning and knowledge from the Accelerating Children’s HIV/AIDS Treatment (ACT) Initiative

ACT supplement

Baylor-Malawi, with USAID funding, has developed a special JAIDS supplement featuring 11 articles which highlight lessons and best practices from the Accelerating Children’s HIV/AIDS Treatment (ACT) Initiative, a public-private partnership that expanded pediatric HIV services in nine sub-Saharan African countries from 2014-2016, providing treatment to more than 560,000 children living with HIV.

Articles include:

  1. ACTing in partnership to accelerate impact
  2. Multi-month prescription of antiretroviral therapy amongst children & adolescents: experiences from the Baylor International Pediatric AIDS initiative in six African countries 
  3. Community-based interventions to reach 95-95-95 for children & adolescents: An exploratory programmatic review from Lesotho
  4. Family testing: An index case finding strategy to close the gaps in pediatric HIV diagnosis 
  5. Strategies for identifying & linking HIV-infected infants, children & adolescents to HIV treatment services in resource limited settings 
  6. Beyond early infant diagnosis: changing the approach to HIV-exposed infants
  7. Zvandiri: Bringing an HIV programme to scale for children, adolescents & young people in Zimbabwe
  8. The case for family-centred differentiated service delivery for HIV 
  9. Getting treatment & care services right for children & adolescents to reach high viral suppression 
  10. Pediatric HIV treatment gaps in seven East & Southern African Countries: Examination of modeled data, survey data & routine program data 
  11. Sustainability & ACT Initiative: Lessons for the next treatment surge
July 25, 2018
Year of publication
Resource types
Journal and research articles
Accelerating Children’s HIV/AIDS Treatment (ACT) Initiative, pediatric ART, community-based interventions, index cases, case finding, early infant diagnosis (EID), linkage to care, differentiated service delivery, pediatric HIV

Similar Resources

The Accelerating Children’s HIV/AIDS Treatment (ACT) Initiative was a public-private partnership that expanded pediatric HIV services in nine sub-Saharan African countries from 2014-2016, providing treatment to more than 560,000 children living with HIV.

Initiation of antiretroviral therapy (ART) following diagnosis of HIV infection at birth is an emerging area of paediatric HIV care. We present outcomes of HIV-infected infants identified at birth at Rahima Moosa Mother and Child Hospital in Johannesburg, South Africa.

An essential first step in caring for HIV-infected children is accurate and early diagnosis of HIV, early HIV testing, prompt return of results, and rapid initiation of treatment.

This study aimed to evaluate the impact of clinic-based prevention of mother-to-child transmission (PMTCT) community support by trained lay health workers in addition to standard clinical care on PMTCT infant outcomes.

Many countries are working to reduce or eliminate mother-to-child transmission (MTCT) of HIV. Prevention efforts have been conceptualized as steps in a cascade but cascade completion rates during and after pregnancy are low.

To understand the uptake of HIV services by adolescent women, the authors conducted a retrospective analysis of patient-level data (2011–2013) on services for antenatal care (ANC) and prevention of mother-to-child transmission (PMTCT) in 36 facilities in 5 districts in Zimbabwe.

This paper documents the development of the global and national monitoring and reporting systems for PMTCT and paediatric HIV care and treatment programmes, achievements and remaining challenges.

In 2013, Uganda updated its prevention of maternal-to-child transmission of HIV program to Option B+, which requires that all HIV-infected pregnant and breastfeeding women be started on lifelong antiretroviral therapy (ART) regardless of CD4 count…

Remarkable progress is being made on HIV treatment. Ahead of World AIDS Day, UNAIDS has launched a new report showing that access to treatment has risen significantly. In 2000, just 685 000 people living with HIV had access to antiretroviral therapy.

Timely access to antiretroviral treatment (ART) is vital to ensuring safe motherhood and reducing vertical transmission. Treatment guidance and programming has changed dramatically in recent years.